Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.

Lancet
Margaret MayIeDEA Southern Africa and West Africa

Abstract

Prognostic models have been developed for patients infected with HIV-1 who start combination antiretroviral therapy (ART) in high-income countries, but not for patients in sub-Saharan Africa. We developed two prognostic models to estimate the probability of death in patients starting ART in sub-Saharan Africa. We analysed data for adult patients who started ART in four scale-up programmes in Côte d'Ivoire, South Africa, and Malawi from 2004 to 2007. Patients lost to follow-up in the first year were excluded. We used Weibull survival models to construct two prognostic models: one with CD4 cell count, clinical stage, bodyweight, age, and sex (CD4 count model); and one that replaced CD4 cell count with total lymphocyte count and severity of anaemia (total lymphocyte and haemoglobin model), because CD4 cell count is not routinely measured in many African ART programmes. Death from all causes in the first year of ART was the primary outcome. 912 (8.2%) of 11 153 patients died in the first year of ART. 822 patients were lost to follow-up and not included in the main analysis; 10 331 patients were analysed. Mortality was strongly associated with high baseline CD4 cell count (>/=200 cells per muL vs <25; adjusted hazard ratio 0.21, 95%...Continue Reading

Citations

Oct 4, 2011·Transactions of the Royal Society of Tropical Medicine and Hygiene·Johan van Griensven, Sopheak Thai
Dec 15, 2012·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Karl Peltzer
Jan 11, 2014·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Karl Peltzer
Dec 14, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward J Mills, Nathan Ford
Nov 10, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Gilles WandelerUNKNOWN SolidarMed ART program and IeDEA-Southern Africa
Jan 14, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Serena P KoenigJean W Pape
Mar 22, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew P FoxUNKNOWN IeDEA-SA collaboration
Jun 5, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mark J GigantiBenjamin H Chi
Dec 21, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Edva NoelSerena P Koenig
Jan 1, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Delphine GabillardUNKNOWN ANRS 12222 Morbidity Mortality Study Group
Jun 13, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Richard J LessellsMarie-Louise Newell
Jul 13, 2011·BMC Infectious Diseases·Asgeir JohannessenJohan N Bruun
Oct 18, 2012·International Journal for Equity in Health·Phyllis Dako-GyekeAlfred E Yawson
Feb 22, 2012·AIDS Research and Therapy·Alan R LifsonUNKNOWN Infectious Disease Clinical Research Program HIV/STI Working Group
Jan 27, 2011·PLoS Medicine·Matthias EggerUNKNOWN IeDEA East Africa, West Africa and Southern Africa
Feb 22, 2012·PLoS Medicine·Edward J MillsMark R Dybul
Sep 14, 2012·PLoS Medicine·Morna CornellUNKNOWN International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration
Mar 5, 2013·PloS One·Duc Bui NguyenBruce Baird Struminger
Jan 24, 2014·PloS One·Veronicah MugishaUNKNOWN Identifying Optimal Models for HIV Care in Rwanda Collaboration

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.